A multicenter, non-interventional observational study to evaluate 1-year clinical outcomes in acute coronary syndrome (ACS) patients undergoing percutaneous coronary interventions (PCI) and Prasugrel therapy.
Not Applicable
Completed
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0002356
- Lead Sponsor
- Daiichi-Sankyo Korea
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 3213
Inclusion Criteria
1) over 19 year
2) Acute coronary syndrome-Percutaneous Coronary Intervention patients treated with prasugrel according to the labeled indication
3) Patients who initiate or switch to prasugrel within 6 months after Percutaneous Coronary Intervention
4) Patients who gie voluntary written informed consent to participate in the study
Exclusion Criteria
1) Patients who are not simultaneously participating in interventional study administering of antiplatelet agents except prasugrel/antithrombotic agents
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method et clinical events: Death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, non-CABG related TIMI major bleeding
- Secondary Outcome Measures
Name Time Method Individual incidence: Death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, non-CABG related TIMI major bleeding